A preclinical study finds that combining atovaquone with platelet-derived growth factor receptor inhibitors reduced ovarian cancer tumoroid viability.

A medication that has long been used to treat high blood pressure could also help make an important class of cancer drugs ...

Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer ...

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a clinical-stage oncology ...

BioLineRx & Hemispherian announce new preclinical data demonstrating strong synergistic effect between GLIX1 and PARP inhibitor in a patient-derived ovarian cancer xenograft model ...

A Berlin-based team from HZB and Center for the Science of Materials Berlin (CSMB) at Humboldt-Universität zu Berlin has set a new record for a tandem solar cell. Using a combination of a CIGS ...

A tandem solar cell combining CIGS and perovskite semiconductors has set a new efficiency record, demonstrating the potential ...

Berlin team's efficiency record for 1.081cm 2 cell certified in the Solar Cell Efficiency 'Green" Tables A Berlin-based team ...

By analyzing fabrication methods and interface design, the authors identify key factors that control efficiency, speed, and stability, and outline practical guidelines for developing more reliable ...

Researchers have cracked the code behind bacteria's ability to naturally manufacture multiple versions of powerful anti-cancer drugs. The discovery could make it much easier to engineer new cancer ...

Practice-changing perioperative therapy, chemo-free combo for CSPC, reducing cognitive eff ...

Researchers from Germany’s Helmholtz-Zentrum Berlin (HZB) and Humboldt-Universität in Germany claim to have achieved a world ...